Brand Name Justification (Naloxone Oral Syringes) KO Signed._Redacted.pdf

This document is a Memorandum for Record (MFR) for limiting competition for a contract by the Department of Pharmacy at BAMC (Brooke Army Medical Center). The contract is for 1,413 naloxone oral syringes annually, with a base plus 4-year term (5 years total), using Purchase Order Number W81K0022P0048. The syringes are an emergency treatment for opioid overdose patients, enabling quick reversal of overdose effects and potentially saving lives. The contract is funded through Operations & Maintenance, Army (OMA) and Other Funds: DHP, with a fiscal year of 2026. The contract period of performance is from 01 October 2025 to 30 September 2030. The procurement will use fixed pricing, and while a brand name is being requested, competition is anticipated and this is not a sole source requirement.